Prostate Cancer
Conditions
Interventions
Observation group of Metastatic hormone-sensitive prostate cancer:None
Sponsors
Affiliated Hospital of Guizhou Medical University
Eligibility
Sex/Gender
Male
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: 1.Men over the age of 18 2. Newly diagnosed mHSPC patients 3. Good physical condition, with an ECOG score of 0-1 4. The patient voluntarily participated in the study and signed the informed consent form
Exclusion criteria
Exclusion criteria: 1. Previously received second-generation anti-androgen therapy (such as abiraterone, apatamide, enzalutamide, rivelutamide), etc 2. Combined with other malignant tumors 3. Previous history of radiotherapy and chemotherapy 4. There are serious cardiovascular diseases (such as myocardial infarction, heart failure or unstable angina pectoris) 5. Patients who are allergic to any of the ingredients used in darotamine or ADT treatment 6. Patients who were considered unsuitable for the study by other researchers
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The duration of PSA < 0.2ng/ml; | — |
Secondary
| Measure | Time frame |
|---|---|
| Overall survival;Safety;Proportion of drug withdrawal;Advances in Imaging;Progress of PSA; | — |
Countries
China
Contacts
Public ContactGe Huixin
Affiliated Hospital of Guizhou Medical University
Outcome results
None listed